156 related articles for article (PubMed ID: 7017560)
1. [Current advances in cancer immunotherapy (author's therapy)].
Belpomme D; Marty M; Gisselbrecht C; Mignot L; Pujade-Lauraine E
Pathol Biol (Paris); 1981 Mar; 29(3):179-88. PubMed ID: 7017560
[TBL] [Abstract][Full Text] [Related]
2. [Current advances in cancer immunotherapy (author's transl)].
Belpomme D; Marty M; Gisselbrecht C; Mignot L; Pujade-Lauraine E
Sem Hop; 1981 Oct 8-15; 57(37-38):1547-56. PubMed ID: 6270825
[TBL] [Abstract][Full Text] [Related]
3. [Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)].
Ogura T
Kekkaku; 1980 Aug; 55(8):359-63. PubMed ID: 6999203
[No Abstract] [Full Text] [Related]
4. [Immunotherapy in neoplasms. Part II--methods (author's transl)].
Szmigiel Z; Skotnicki AB
Przegl Lek; 1975; 32(9):706-11. PubMed ID: 242038
[No Abstract] [Full Text] [Related]
5. Immunomodulation with antibodies: clinical application in ovarian cancer and other malignancies.
Nicodemus CF; Schultes BC; Hamilton BL
Expert Rev Vaccines; 2002 Jun; 1(1):35-48. PubMed ID: 12908511
[TBL] [Abstract][Full Text] [Related]
6. [Immunology and immunotherapy of malignant tumors: balance and prospects 1978].
Nagel GA
Schweiz Med Wochenschr; 1978 Aug; 108(32):1228-32. PubMed ID: 307815
[TBL] [Abstract][Full Text] [Related]
7. Tumor vaccine: current trends in antigen specific immunotherapy.
Baral R
Indian J Exp Biol; 2005 May; 43(5):389-406. PubMed ID: 15900903
[TBL] [Abstract][Full Text] [Related]
8. [Possibilities of immunotherapy of human tumors].
Fekete B
Orv Hetil; 1992 Sep; 133(36):2271-3. PubMed ID: 1408060
[No Abstract] [Full Text] [Related]
9. [Cancer immunotherapy in dermatological view (author's transl)].
Lübbe D; Gstöttner R
Arch Geschwulstforsch; 1980; 50(2):182-5. PubMed ID: 7436703
[TBL] [Abstract][Full Text] [Related]
10. Cancer immunotherapy.
Baxevanis CN; Perez SA; Papamichail M
Crit Rev Clin Lab Sci; 2009; 46(4):167-89. PubMed ID: 19650714
[TBL] [Abstract][Full Text] [Related]
11. Active immunization against cancer cells: impediments and advances.
Velders MP; Schreiber H; Kast WM
Semin Oncol; 1998 Dec; 25(6):697-706. PubMed ID: 9865683
[TBL] [Abstract][Full Text] [Related]
12. Complications of BCG immunotherapy in patients with cancer.
Sparks FC; Silverstein MJ; Hunt JS; Haskell CM; Pilch YH; Morton DL
N Engl J Med; 1973 Oct; 289(16):827-30. PubMed ID: 4763426
[No Abstract] [Full Text] [Related]
13. Clinical results of vaccine therapy for cancer: learning from history for improving the future.
Choudhury A; Mosolits S; Kokhaei P; Hansson L; Palma M; Mellstedt H
Adv Cancer Res; 2006; 95():147-202. PubMed ID: 16860658
[TBL] [Abstract][Full Text] [Related]
14. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
15. Bio-immunotherapy for cancer in experimental studies and clinical application: current status and future challenges.
Shen RN; Lu L; Kaiser HE; Broxmeyer HE
In Vivo; 1994; 8(5):643-52. PubMed ID: 7727711
[TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. Live bacteria as the basis for immunotherapies against cancer.
Chabalgoity JA; Dougan G; Mastroeni P; Aspinall RJ
Expert Rev Vaccines; 2002 Dec; 1(4):495-505. PubMed ID: 12901588
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of cancer: a critical review.
Lutz D
Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):118-29. PubMed ID: 6343261
[TBL] [Abstract][Full Text] [Related]
19. BCG: A note of caution.
Bluming AZ
N Engl J Med; 1973 Oct; 289(16):860-1. PubMed ID: 4763431
[No Abstract] [Full Text] [Related]
20. A fresh look at tumor immunosurveillance and immunotherapy.
Smyth MJ; Godfrey DI; Trapani JA
Nat Immunol; 2001 Apr; 2(4):293-9. PubMed ID: 11276199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
